Jing et al. investigated the role of RIG-I in NPC resistant to both radiotherapy and chemotherapy and found that RIG-I expression was significantly reduced in chemoradiotherapy-resistant NPC tissues and cells [64]. The gene discussed is RIGI; the disease is nasopharyngeal carcinoma.